AstraZeneca Covid-19 vaccine benefits outweigh risks, European Medicines Agency reiterates
From CNN’s James Frater
A doctor holds a vial of the AstraZeneca vaccine at a drive-thru clinic in Milan, Italy, on March 15. Pier Cruciatti/Anadolu Agency/Getty Images
The benefits of the AstraZeneca Covid-19 vaccine outweigh the risks, and the number of people developing blood clots after vaccination does not seem to be higher than in the general population, the European Medicines Agency (EMA) said Monday.
The statement comes after Germany, France and Italy announced temporary suspensions of use of the vaccine.
The agency said it would hold an emergency meeting on Thursday to advise on “any further actions that may need to be taken.”